Reihling Hanspeter C W
Institute for Social Anthropology, Freie Universität Berlin, Landoltweg 9-11, 14195 Berlin, Germany.
J Ethnobiol Ethnomed. 2008 Mar 27;4:9. doi: 10.1186/1746-4269-4-9.
This article gives an overview of anthropological research on bioprospecting in general and of available literature related to bioprospecting particularly in South Africa. It points out how new insights on value regimes concerning plant-based medicines may be gained through further research and is meant to contribute to a critical discussion about the ethics of Access and Benefit Sharing (ABS). In South Africa, traditional healers, plant gatherers, petty traders, researchers and private investors are assembled around the issues of standardization and commercialization of knowledge about plants. This coincides with a nation-building project which promotes the revitalization of local knowledge within the so called African Renaissance. A social science analysis of the transformation of so called Traditional Medicine (TM) may shed light onto this renaissance by tracing social arenas in which different regimes of value are brought into conflict. When medicinal plants turn into assets in a national and global economy, they seem to be manipulated and transformed in relation to their capacity to promote health, their market value, and their potential to construct new ethics of development. In this context, the translation of socially and culturally situated local knowledge about muthi into global pharmaceuticals creates new forms of agency as well as new power differentials between the different actors involved.
本文概述了人类学对生物勘探的总体研究,以及特别是与南非生物勘探相关的现有文献。它指出,通过进一步研究,如何能够获得关于植物性药物价值体系的新见解,并且旨在促进关于获取与惠益分享(ABS)伦理的批判性讨论。在南非,传统治疗师、植物采集者、小商贩、研究人员和私人投资者围绕植物知识的标准化和商业化问题聚集在一起。这与一个国家建设项目相契合,该项目在所谓的非洲复兴中促进本土知识的复兴。对所谓传统医学(TM)转变的社会科学分析,通过追溯不同价值体系发生冲突的社会领域,可能会揭示这一复兴。当药用植物在国家和全球经济中变成资产时,它们似乎会根据其促进健康的能力、市场价值以及构建新的发展伦理的潜力而受到操纵和转变。在这种背景下,将关于传统药物的社会和文化情境化的本土知识转化为全球药品,会创造出新的行动形式以及不同相关行为者之间新的权力差异。